Status:
COMPLETED
Study Comparing BoneMaster Hydroxyapatite Coating With Plasma-sprayed Hydroxyapatite Coating on Acetabular Cups
Lead Sponsor:
Zimmer Biomet
Conditions:
Arthropathy of Hip
Eligibility:
All Genders
Phase:
NA
Brief Summary
The randomised controlled trial will be carried out on patients that require a total hip replacement (THR) to reduce pain and restore their function. One way of fixing the hip joint to the bone is by ...
Detailed Description
The patients will be identified by the orthopaedic surgeon in the orthopaedic clinic and deemed suitable for the study if all inclusion and exclusion criteria are met. 210 patients will be recruited t...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients suitable for THR surgery with a diagnosis of Osteoarthritis
- Patients aged 40 -85 years old.
- Patients with limited co-morbidity - ASA I - III (low risk for surgery)
- Patients must be able to understand instructions and be willing to return for follow up
- Exclusion Criteria
- Rheumatoid arthritis
- Patients requiring supplemental screw fixation
- Previous hip surgery to the affected hip
- Patients with significant co-morbidity - ASA IV - V (high risk for surgery)
- Dementia
- Neurological conditions affecting everyday functional ability and hip movement
- The patient is unable to give informed consent
- Patients who have suffered from cancer
- The patient is currently part of another research study
- Patients who need to take Non Steroidal Anti-inflammatory Drugs (NSAIDs) in the first 6 weeks after surgery
Exclusion
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT00859976
Start Date
March 1 2009
End Date
May 1 2014
Last Update
March 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William Harvey Hospital
Ashford, Kent, United Kingdom, TN24 0LZ